⌘K

Login Start Free

Home/Filings/4/0001223692-09-000024

4//SEC Filing

McManus John L 4

Accession 0001223692-09-000024

CIK 0001261734other

View on SEC.gov Company Profile

Filed

Jul 29, 8:00 PM ET

Accepted

Jul 30, 5:16 PM ET

Size

6.2 KB

Accession

0001223692-09-000024

Insider Transaction Report

Form 4

Period: 2009-07-30

AEOLUS PHARMACEUTICALS, INC.AOLS

President & CEO

Transactions

Award
Non-Qualified Stock Option (right to buy)
2009-07-30+250,000→ 250,000 total
Exercise: $0.39Exp: 2019-07-30→ Common Stock (250,000 underlying)

Footnotes (1)

[F1]Options will vest at a rate of 20,833 per month from the grant date for twelve months, provided that John McManus is an employee or consultant of Aeolus on the applicable vesting date. In the event of a sale of Aeolus, through a merger or otherwise, all of the options shall be fully vested and immediately exercisable.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

AEOLUS PHARMACEUTICALS, INC.

CIK 0001261734

Entity typeother

Related Parties

1

filerCIK 0001193923

Filing Metadata

Form type: 4
Filed: Jul 29, 8:00 PM ET
Accepted: Jul 30, 5:16 PM ET
Size: 6.2 KB

View on SEC.gov